CDH2 and melanoma: This is also supported by melanoma TCGA data analysis where we found that composite high mRNA expressions of PLK1 and N-cadherin significantly decreased overall survival of melanoma patients, and low PLK1 with high E-cadherin expression was associated with a trend of higher overall survival.